Skip to main content
Account

Peer review reports

From: CpG ODN (K3)—toll-like receptor 9 agonist—induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study

Original Submission
21 Jul 2021 Submitted Original manuscript
22 Sep 2021 Reviewed Reviewer Report
11 Oct 2021 Reviewed Reviewer Report
8 Nov 2021 Author responded Author comments - Tomoyuki Otsuka
Resubmission - Version 2
8 Nov 2021 Submitted Manuscript version 2
23 Feb 2022 Reviewed Reviewer Report
3 Mar 2022 Reviewed Reviewer Report
24 May 2022 Author responded Author comments - Tomoyuki Otsuka
Resubmission - Version 3
24 May 2022 Submitted Manuscript version 3
9 Jun 2022 Author responded Author comments - Tomoyuki Otsuka
Resubmission - Version 4
9 Jun 2022 Submitted Manuscript version 4
Publishing
24 Jun 2022 Editorially accepted
7 Jul 2022 Article published 10.1186/s12885-022-09818-4

Learn about peer review

Back to article page

Navigation